 |
PDBsum entry 2anj
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
2anj
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Membrane protein
|
 |
|
Title:
|
 |
Crystal structure of the glur2 ligand binding core (s1s2j-y450w) mutant in complex with the partial agonist kainic acid at 2.1 a resolution
|
|
Structure:
|
 |
Glutamate receptor 2. Chain: a. Fragment: ligand binding core. Synonym: glur-2, glur-b, glur-k2, glutamate receptor ionotropic, ampa 2. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Rattus norvegicus. Norway rat. Organism_taxid: 10116. Gene: gria2, glur2. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.187
|
R-free:
|
0.248
|
|
|
Authors:
|
 |
M.M.Holm,P.Naur,B.Vestergaard,M.T.Geballe,M.Gajhede,J.S.Kastrup, S.F.Traynelis,J.Egebjerg
|
Key ref:
|
 |
M.M.Holm
et al.
(2005).
A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study.
J Biol Chem,
280,
35469-35476.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
11-Aug-05
|
Release date:
|
30-Aug-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P19491
(GRIA2_RAT) -
Glutamate receptor 2 from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
883 a.a.
262 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 5 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
280:35469-35476
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study.
|
|
M.M.Holm,
P.Naur,
B.Vestergaard,
M.T.Geballe,
M.Gajhede,
J.S.Kastrup,
S.F.Traynelis,
J.Egebjerg.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Binding of an agonist to the
2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)-propionic acid (AMPA) receptor
family of the glutamate receptors (GluRs) results in rapid activation of an ion
channel. Continuous application results in a non-desensitizing response for
agonists like kainate, whereas most other agonists, such as the endogenous
agonist (S)-glutamate, induce desensitization. We demonstrate that a highly
conserved tyrosine, forming a wedge between the agonist and the N-terminal part
of the bi-lobed ligand-binding site, plays a key role in the receptor kinetics
as well as agonist potency and selectivity. The AMPA receptor GluR2, with
mutations in Tyr-450, were expressed in Xenopus laevis oocytes and characterized
in a two-electrode voltage clamp setup. The mutation GluR2(Y450A) renders the
receptor highly kainate selective, and rapid application of kainate to
outside-out patches induced strongly desensitizing currents. When Tyr-450 was
substituted with the larger tryptophan, the (S)-glutamate desensitization is
attenuated with a 10-fold increase in steady-state/peak currents (19% compared
with 1.9% at the wild type). Furthermore, the tryptophan mutant was introduced
into the GluR2-S1S2J ligand binding core construct and co-crystallized with
kainate, and the 2.1-A x-ray structure revealed a slightly more closed ligand
binding core as compared with the wild-type complex. Through genetic
manipulations combined with structural and electrophysiological analysis, we
report that mutations in position 450 invert the potency of two central agonists
while concurrently strongly shaping the agonist efficacy and the desensitization
kinetics of the AMPA receptor GluR2.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIGURE 1. Structure of ionotropic glutamate receptors and
ligands. A, an individual subunit is highlighted on the left and
is formed by a single polypeptide chain beginning with the
N-terminal LIVBP (leucine-isoleucine-valine-binding
protein)-like domain, which is followed by S1 forming the
majority of domain 1 (D1) of the ligand binding core (red). The
amino acid chain then transverses domain 2 (D2) of the ligand
binding core and forms M1, the P-loop, and M2. Subsequently, the
rest of domain 2 (D2, blue) is formed by S2, ending up in the
last transmembrane -helix (M3) and the
intracellular C-terminal domain. The flip/flop region lies on
the back, primarily of the D1. Scissors indicate where the
corresponding receptor has been cleaved during construction of
the GluR2-S1S2J construct. B, structures of selected AMPA
receptor agonists.
|
 |
Figure 7.
FIGURE 7. Details of the structure of GluR2-S1S2J(Y450W) in
complex with kainate. A, schematic representation of the overall
structure of GluR2-S1S2J(Y450W) with zoom on a F[o] - F[c] omit
map contoured at 3.0 for kainate (blue in D1
and green in D2). B, stereo view of the ligand binding pocket of
GluR2-S1S2J(Y450W) showing the hydrogen-bonding network to
kainate (black). C, comparison of the ligand binding pocket of
wild-type GluR2-S1S2J (6) (PDB code 1FT0 [PDB]
, black) and GluR2-S1S2J(Y450W) (blue in D1 and green in D2),
both in complex with kainate. The side chain of residue 450 is
depicted showing the 6° difference of the aromatic wedge.
Nitrogen atoms are blue, oxygen atoms are red, and sulfur atoms
are yellow. The figure was prepared using Molscript (36) and
Raster3d (37).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
35469-35476)
copyright 2005.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Pøhlsgaard,
K.Frydenvang,
U.Madsen,
and
J.S.Kastrup
(2011).
Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators.
|
| |
Neuropharmacology,
60,
135-150.
|
 |
|
|
|
|
 |
V.A.Muñiz,
S.Srinivasan,
S.A.Boswell,
D.W.Meinhold,
T.Childs,
R.Osuna,
and
W.Colón
(2011).
The role of the local environment of engineered Tyr to Trp substitutions for probing the denaturation mechanism of FIS.
|
| |
Protein Sci,
20,
302-312.
|
 |
|
|
|
|
 |
A.Birdsey-Benson,
A.Gill,
L.P.Henderson,
and
D.R.Madden
(2010).
Enhanced efficacy without further cleft closure: reevaluating twist as a source of agonist efficacy in AMPA receptors.
|
| |
J Neurosci,
30,
1463-1470.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.K.Fenwick,
and
R.E.Oswald
(2008).
NMR spectroscopy of the ligand-binding core of ionotropic glutamate receptor 2 bound to 5-substituted willardiine partial agonists.
|
| |
J Mol Biol,
378,
673-685.
|
 |
|
|
|
|
 |
K.A.Mankiewicz,
A.Rambhadran,
M.Du,
G.Ramanoudjame,
and
V.Jayaraman
(2007).
Role of the chemical interactions of the agonist in controlling alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation.
|
| |
Biochemistry,
46,
1343-1349.
|
 |
|
|
|
|
 |
P.Bannerman,
M.Horiuchi,
D.Feldman,
A.Hahn,
A.Itoh,
J.See,
Z.P.Jia,
T.Itoh,
and
D.Pleasure
(2007).
GluR2-free alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors intensify demyelination in experimental autoimmune encephalomyelitis.
|
| |
J Neurochem,
102,
1064-1070.
|
 |
|
|
|
|
 |
A.Priel,
S.Selak,
J.Lerma,
and
Y.Stern-Bach
(2006).
Block of kainate receptor desensitization uncovers a key trafficking checkpoint.
|
| |
Neuron,
52,
1037-1046.
|
 |
|
|
|
|
 |
M.L.Mayer
(2006).
Glutamate receptors at atomic resolution.
|
| |
Nature,
440,
456-462.
|
 |
|
|
|
|
 |
P.E.Chen,
and
D.J.Wyllie
(2006).
Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors.
|
| |
Br J Pharmacol,
147,
839-853.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |